Fmoc-D-Norvaline is a protected, non-proteinogenic stereodefined amino acid derivative featuring the D-configured norvaline (2-aminopentanoic acid) backbone bearing a side-chain with a straight-chain propyl group. The amino group is protected as an Fmoc carbamate, while the carboxyl group remains available for peptide-coupling chemistry, enabling the molecule to function as an activated building block for controlled amide-bond formation. In peptide synthesis workflows, Fmoc-D-norvaline can be used as a stepwise incorporation unit on solid-phase or in protected amino acid strategies to introduce the D-norvaline residue into peptides for structure-activity studies, conformational analysis, or chemical biology labeling where stereochemical variation is required.
CAT No: CP08607
CAS No:144701-24-6
Synonyms/Alias:Fmoc-D-Nva-OH;144701-24-6;Fmoc-D-norvaline;(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)pentanoicacid;ST51037598;AC1MBSTO;PubChem14960;SCHEMBL119530;CTK8C4801;MolPort-003-725-665;ZINC2530815;ANW-73162;AM82598;AJ-38515;AK106109;KB-52054;RT-012951;FT-0643367;V3347;J-300351;I14-37317;(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)pentanoicacid;(2R)-2-[(fluoren-9-ylmethoxy)carbonylamino]pentanoicacid;(2R)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}pentanoicacid
Fmoc-D-Norvaline is a D-configured norvaline derivative bearing an N-(9H-fluoren-9-ylmethoxycarbonyl) (Fmoc) protecting group, giving a chiral amino acid building block with an Fmoc-protected secondary amine and a free carboxylic acid. The side chain is a straight-chain aliphatic propyl group that can participate in hydrophobic interactions during peptide assembly and can be further transformed for side-chain functionalization. The stereogenic center at the alpha carbon provides stereochemical control for incorporation into peptides and for preparing D-amino acid analogs used in structure-activity relationship studies. The combination of an acid functionality and an orthogonally removable Fmoc group supports standard peptide coupling chemistry while enabling downstream conversion into activated intermediates for fine chemical synthesis.
1. Peptide Synthesis
Fmoc-D-Norvaline is used in peptide building workflows where Fmoc-based solid-phase peptide synthesis or related coupling strategies require a stable, base-labile N-protection scheme. The Fmoc-protected D-amino acid format presents a carboxylic acid for amide bond formation while maintaining the D-configuration at the stereocenter during assembly. Side-chain propyl hydrophobicity can be leveraged to tune folding propensity, backbone packing, and conformational preferences of peptide sequences containing D-residues. The resulting D-norvaline incorporation enables preparation of stereochemically defined peptide fragments and longer constructs for biochemical research and peptidomimetic studies.
2. Peptidomimetics And SAR
Fmoc-D-Norvaline is applied in medicinal chemistry research focused on peptidomimetics and structure-activity relationship studies where D-amino acid incorporation is used to probe stereochemical effects on molecular recognition. The D-configuration and unfunctionalized aliphatic side chain provide a controlled hydrophobic element that can modulate binding site interactions without introducing additional reactive groups. Fmoc removal and subsequent coupling allow systematic replacement of L-residues with D-norvaline to map stereochemical determinants across a scaffold. Downstream peptide analog generation can feed into SAR libraries and fragment-based molecular design efforts that require consistent amino acid building blocks.
3. Side-Chain Functionalization
Fmoc-D-Norvaline serves as a chiral starting material for side-chain modification routes that begin from the protected amino acid and proceed through derivatization of the aliphatic propyl chain. The Fmoc-protected amine and carboxylic acid handle can be orthogonally managed to enable selective activation of the acid for coupling or conversion into activated esters/amides prior to side-chain transformations. D-norvaline stereochemistry can be retained through protected intermediate steps to generate stereodefined analogs for chemical biology probes. The resulting functionalized D-amino acid derivatives can be used to construct conjugatable peptidomimetics, hydrophobic spacers, or intermediate fragments for specialty chemical production.
4. Protein Engineering
Fmoc-D-Norvaline is relevant to protein engineering and synthetic protein design programs that incorporate noncanonical amino acids or D-residue analogs to alter stability and protease resistance profiles of engineered sequences. The Fmoc-protected amino acid form supports controlled introduction of D-norvaline into peptide segments that may later be assembled into larger biomolecular constructs. The combination of a protected amine and a carboxyl group enables stepwise construction of defined sequence motifs for studying how D-amino acid placement affects local structure and intermolecular interactions. The D-configured aliphatic side chain can function as a tunable hydrophobic contact in engineered peptide domains, supporting downstream generation of protein-like materials and research-grade biomolecule variants.
5. Pharmaceutical Intermediate Preparation
Fmoc-D-Norvaline is suitable for pharmaceutical intermediate preparation where protected amino acid derivatives are required for controlled synthesis of D-amino acid-containing intermediates and peptide-derived building blocks. The Fmoc group provides a robust N-protection strategy compatible with common peptide coupling conditions and can be removed under standard base conditions to expose the reactive amine for subsequent transformations. The free carboxylic acid functionality allows conversion to activated species for amide bond formation in manufacturing-relevant synthetic sequences. The stereodefined D-amino acid intermediate can be employed to manufacture peptidomimetic fragments, chiral amide intermediates, and downstream fine chemical products that depend on maintaining D-configuration through the synthetic route.
2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.